Bioavailability, Drug Delivery Systems, Gene Therapy and Protein

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Bioavailability

Drug Delivery Systems

Gene Therapy

Protein

Biopharmaceutical Excipient Manufacturing – Current Scenario and Future Trends

Roots Analysis

MARCH 13, 2022

In the last decade alone, the annual number of approvals of biopharmaceuticals (including monoclonal antibodies, recombinant proteins, vaccines and gene therapies), by the US FDA, have steadily risen. Over the years, the rising popularity of biologics has led to a paradigm shift in the healthcare industry. Web: [link].

Manufacturing

Manufacturing Drug Delivery Marketing Drug Delivery Systems

Considerations for Neuroscience Trials with Intrathecal Delivery and Other Methods of Direct CNS Administration

XTalks

AUGUST 30, 2022

We know that a lot of different pathologies, especially as we’ve entered the era of molecular medicine and gene therapies, cause many of the same symptoms and work through final common pathways. Sometimes we can engage with the target that we’re interested in, but very often these drugs get through the entire brain.

Trials

Trials Drug Delivery Drugs Gene

Clinical Research Informer

Biopharmaceutical Excipient Manufacturing – Current Scenario and Future Trends

Considerations for Neuroscience Trials with Intrathecal Delivery and Other Methods of Direct CNS Administration

Stay Connected